[Further results of new therapy of Parkinsonian syndromes; therapeutic action of 3-phenyl-3-b-diethylamino-ethyl-2-6-dioxy-piperidine hydrochloride administered alone and with reserpine and ritalin].
作者信息
GIBERTI F, GIANNIOTTI G, SPIZZIRRI S
出版信息
Gazz Med Ital. 1957 Sep;116(9):404-7.
PMID:13480469
Abstract
摘要
相似文献
1
2
3
Ritalin and serpasil in the treatment of Parkinson's disease.
Dis Nerv Syst. 1956 Nov;17(11):363-4.
4
[Clinical observations on the association of reserpine with phenyl-piperidyl-2-methyl acetate HCI (ritalin) in arterial hypertension].
G Clin Med. 1956 Jul;37(7):1010-5.
5
[Therapeutic effects of drug antagonists; combined reserpine-ritalin (serpatonil)].
Prensa Med Argent. 1957 Oct 4;44(40):3017-9.
6
[Comparative therapeutic effect of serpasil-ritalin combination].
Schweiz Med Wochenschr. 1956 Nov 17;86(46):1318-21.
7
Action of methyl-phenidylacetate (ritalin) and reserpine in behavior disorders in children and adults.
Am J Psychiatry. 1958 Oct;115(4):323-8. doi: 10.1176/ajp.115.4.323.
8
Combined ritalin and serpasil therapy in chronic psychoses.
Dis Nerv Syst. 1958 Mar;19(3):122-36.
9
[Observations on neurotic depressions with reference to a combined serpasil-ritalin treatment].
Rass Neuropsichiatr. 1956;10(5-6):198-209.
10
Treatment of hypertension using reserpine combined with a new analeptic agent, methyl-phenidylacetate hydrochloride; limitations of usefulness.
Antibiotic Med Clin Ther (New York). 1957 Oct;4(10):602-8.
引用本文的文献
1
Monoamine reuptake inhibitors in Parkinson's disease.单胺再摄取抑制剂在帕金森病中的应用。
Parkinsons Dis. 2015;2015:609428. doi: 10.1155/2015/609428. Epub 2015 Feb 25.
Zotero 插件